Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Nature
|
March 20, 2025
Oncolytic virus VG161 in refractory hepatocellular carcinoma
Yinan Shen, Xueli Bai, Qi Zhang, et al.
The Lancet. Oncology
|
June 18, 2021
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study
Zhenggang Ren, Jianming Xu, Yuxian Bai, et al.
Nature
|
April 24, 2025
Publisher Correction: Oncolytic virus VG161 in refractory hepatocellular carcinoma
Yinan Shen, Xueli Bai, Qi Zhang, et al.
Journal of Cancer Research and Therapeutics
|
October 7, 2022
Clinical practice guidelines on image-guided thermal ablation of primary and metastatic lung tumors (2022 edition)
Xin Ye, Weijun Fan, Zhongmin Wang, et al.
Journal of Cancer Research and Therapeutics
|
December 1, 2021
Expert consensus on thermal ablation therapy of pulmonary subsolid nodules (2021 Edition)
Xin Ye, Weijun Fan, Zhongmin Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
April 25, 2021
[Expert Consensus for Thermal Ablation of Pulmonary Subsolid Nodules (2021 Edition)]
Xin Ye, Weijun Fan, Zhongmin Wang, et al.
Signal Transduction and Targeted Therapy
|
August 6, 2025
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
Chuanhua Zhao, Yanqiao Zhang, Gang Wang, et al.
The Lancet. Gastroenterology & Hepatology
|
May 23, 2025
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
Yinghong Shi, Guohong Han, Jian Zhou, et al.
Journal of Cancer Research and Therapeutics
|
August 29, 2024
Expert consensus on the multidisciplinary diagnosis and treatment of multiple ground glass nodule-like lung cancer (2024 Edition)
Baodong Liu, Xin Ye, Weijun Fan, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Nature
|
March 20, 2025
Oncolytic virus VG161 in refractory hepatocellular carcinoma
Yinan Shen, Xueli Bai, Qi Zhang, et al.
The Lancet. Oncology
|
June 18, 2021
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study
Zhenggang Ren, Jianming Xu, Yuxian Bai, et al.
Nature
|
April 24, 2025
Publisher Correction: Oncolytic virus VG161 in refractory hepatocellular carcinoma
Yinan Shen, Xueli Bai, Qi Zhang, et al.
Journal of Cancer Research and Therapeutics
|
October 7, 2022
Clinical practice guidelines on image-guided thermal ablation of primary and metastatic lung tumors (2022 edition)
Xin Ye, Weijun Fan, Zhongmin Wang, et al.
Journal of Cancer Research and Therapeutics
|
December 1, 2021
Expert consensus on thermal ablation therapy of pulmonary subsolid nodules (2021 Edition)
Xin Ye, Weijun Fan, Zhongmin Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
April 25, 2021
[Expert Consensus for Thermal Ablation of Pulmonary Subsolid Nodules (2021 Edition)]
Xin Ye, Weijun Fan, Zhongmin Wang, et al.
Signal Transduction and Targeted Therapy
|
August 6, 2025
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
Chuanhua Zhao, Yanqiao Zhang, Gang Wang, et al.
The Lancet. Gastroenterology & Hepatology
|
May 23, 2025
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
Yinghong Shi, Guohong Han, Jian Zhou, et al.
Journal of Cancer Research and Therapeutics
|
August 29, 2024
Expert consensus on the multidisciplinary diagnosis and treatment of multiple ground glass nodule-like lung cancer (2024 Edition)
Baodong Liu, Xin Ye, Weijun Fan, et al.
Page
of 8